1. Home
  2. NOTV vs MPA Comparison

NOTV vs MPA Comparison

Compare NOTV & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • MPA
  • Stock Information
  • Founded
  • NOTV 1974
  • MPA 1992
  • Country
  • NOTV United States
  • MPA United States
  • Employees
  • NOTV N/A
  • MPA N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • MPA Finance Companies
  • Sector
  • NOTV Health Care
  • MPA Finance
  • Exchange
  • NOTV Nasdaq
  • MPA Nasdaq
  • Market Cap
  • NOTV 137.5M
  • MPA 139.0M
  • IPO Year
  • NOTV 1997
  • MPA N/A
  • Fundamental
  • Price
  • NOTV $2.05
  • MPA $10.78
  • Analyst Decision
  • NOTV Strong Buy
  • MPA
  • Analyst Count
  • NOTV 1
  • MPA 0
  • Target Price
  • NOTV $5.00
  • MPA N/A
  • AVG Volume (30 Days)
  • NOTV 888.5K
  • MPA 25.2K
  • Earning Date
  • NOTV 08-07-2025
  • MPA 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • MPA 3.83%
  • EPS Growth
  • NOTV N/A
  • MPA N/A
  • EPS
  • NOTV N/A
  • MPA N/A
  • Revenue
  • NOTV $480,402,000.00
  • MPA N/A
  • Revenue This Year
  • NOTV $4.99
  • MPA N/A
  • Revenue Next Year
  • NOTV $5.39
  • MPA N/A
  • P/E Ratio
  • NOTV N/A
  • MPA N/A
  • Revenue Growth
  • NOTV N/A
  • MPA N/A
  • 52 Week Low
  • NOTV $1.15
  • MPA $9.87
  • 52 Week High
  • NOTV $6.48
  • MPA $12.21
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 42.15
  • MPA 47.36
  • Support Level
  • NOTV $2.64
  • MPA $10.65
  • Resistance Level
  • NOTV $3.19
  • MPA $10.80
  • Average True Range (ATR)
  • NOTV 0.33
  • MPA 0.09
  • MACD
  • NOTV -0.09
  • MPA 0.00
  • Stochastic Oscillator
  • NOTV 5.93
  • MPA 48.15

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About MPA Blackrock MuniYield Pennsylvania Quality Fund

Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.

Share on Social Networks: